Analysts, along with Dr. Cole Claiborne discuss AVTX-009 in hidradenitis suppurativa (HS).on an Analyst/Industry conference call to be held on October 22 at 1 pm.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTX:
- Avalo Therapeutics management to meet with Piper Sandler
- Avalo Therapeutics Highlights AVTX-009 Potential in New Presentation
- Avalo Therapeutics Strengthens Leadership with Key Appointments
- Avalo Therapeutics appoints Boyd as CBO, Ivanowicz as SVP, Human Resources
- Avalo Therapeutics Appoints Kevin Lind to Board